AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 45 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $866,000 | -1.6% | 48,466 | -1.6% | 0.00% | -25.0% |
| Q2 2017 | $880,000 | +37.9% | 49,266 | +11.9% | 0.00% | +33.3% |
| Q1 2017 | $638,000 | -29.4% | 44,033 | -10.3% | 0.00% | -25.0% |
| Q4 2016 | $904,000 | -2.1% | 49,089 | +0.9% | 0.00% | 0.0% |
| Q3 2016 | $923,000 | +11.7% | 48,640 | -5.1% | 0.00% | 0.0% |
| Q2 2016 | $826,000 | +75.0% | 51,240 | +30.3% | 0.00% | +100.0% |
| Q1 2016 | $472,000 | -14.5% | 39,325 | +1.4% | 0.00% | 0.0% |
| Q4 2015 | $552,000 | +22.1% | 38,800 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $452,000 | -33.5% | 38,661 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $680,000 | +13.3% | 38,661 | -3.6% | 0.00% | +50.0% |
| Q1 2015 | $600,000 | +8.1% | 40,105 | -16.0% | 0.00% | 0.0% |
| Q4 2014 | $555,000 | +3.5% | 47,772 | +3.8% | 0.00% | 0.0% |
| Q3 2014 | $536,000 | – | 46,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MQS Management LLC | 10,935 | $255,000 | 0.41% |
| GLOBEFLEX CAPITAL L P | 144,692 | $3,370,000 | 0.34% |
| CORNERCAP INVESTMENT COUNSEL INC | 58,975 | $1,374,000 | 0.20% |
| Factorial Partners, LLC | 10,900 | $254,000 | 0.17% |
| FEDERATED HERMES, INC. | 3,464,335 | $80,684,000 | 0.15% |
| Campbell & CO Investment Adviser LLC | 14,800 | $345,000 | 0.12% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 611,462 | $14,241,000 | 0.08% |
| Summit Global Investments | 45,900 | $1,069,000 | 0.07% |
| RENAISSANCE GROUP LLC | 63,559 | $1,480,000 | 0.06% |
| PDT Partners, LLC | 33,459 | $779,000 | 0.06% |